Dietmar Schranz – författare

Right Ventricle in Health and Disease

The Right Ventricle in Health and Disease provides a comprehensive and up-to-date database and collection of the available information which describes the structure and function of the normal right ventricle. The right ventricular performance and function reserve has now finally moved to the center of the stage as clinicians recognize that the drugs presently used to treat patients with severe pulmonary hypertension do not necessarily improve the performance of the right ventricle and because the survival depends on the right ventricular function that treatment strategies need to be developed to primarily protect the right ventricle from failing. In-depth chapters discuss right heart function and failure in patients with congenital heart diseases, review modern imaging techniques used to describe right ventricular form and function in patients with right heart failure (including cardiac MRI and PET scanning), describe ventricular interdependence: the left ventricle in pulmonaryhypertension and discuss the concept of the sick lung circulation and its contribution to right heart failure. Treatment strategies of chronic right heart failure including drugs and mechanical devices are also discussed.

This book is an ideal, up-to-date guide to the application of fetal interventions and hybrid procedures, in which the surgeon and the interventional cardiologist work together, for the treatment of congenital heart diseases at a very early stage when disease outcome may be altered. State of the art data and clear instruction are offered on techniques such as fetal pulmonary and aortic valve dilatation, fetal interatrial septum stenting, hybrid defect closure, hybrid stent implantation, and hypoplastic left heart syndrome therapy. Recognized experts describe the benefits of such early interventions, particularly evident in the case of valve disease, and explain how the hybrid strategy, by combining advantages and tools from each approach, can reduce invasiveness and risks and improve results. The book also looks ahead to the likely impact of new technologies, including nanotechnology, that will soon be available. Fetal and Hybrid Procedures in Congenital Heart Diseases will be a rich source of knowledge, step-by-step guidance, and practical tips and tricks for obstetricians/gynecologists, fetal cardiologists, pediatric cardiologists, interventional cardiologists, congenital cardiac surgeons, anesthesiologists, and intensivists.

This book is an ideal, up-to-date guide to the application of fetal interventions and hybrid procedures, in which the surgeon and the interventional cardiologist work together, for the treatment of congenital heart diseases at a very early stage when disease outcome may be altered. State of the art data and clear instruction are offered on techniques such as fetal pulmonary and aortic valve dilatation, fetal interatrial septum stenting, hybrid defect closure, hybrid stent implantation, and hypoplastic left heart syndrome therapy. Recognized experts describe the benefits of such early interventions, particularly evident in the case of valve disease, and explain how the hybrid strategy, by combining advantages and tools from each approach, can reduce invasiveness and risks and improve results. The book also looks ahead to the likely impact of new technologies, including nanotechnology, that will soon be available. Fetal and Hybrid Procedures in Congenital Heart Diseases will be a rich source of knowledge, step-by-step guidance, and practical tips and tricks for obstetricians/gynecologists, fetal cardiologists, pediatric cardiologists, interventional cardiologists, congenital cardiac surgeons, anesthesiologists, and intensivists.